Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 15, pp. 4196-4205
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 21, 2013
- Revision received May 19, 2013
- Accepted May 20, 2013
- Published first June 11, 2013.
Article Versions
- Previous version (June 11, 2013 - 11:07).
- You are viewing the most recent version of this article.
Copyright & Usage
©2013 American Association for Cancer Research.
Author Information
- Yi Zhang1,
- Catherine A. Schnabel1,
- Brock E. Schroeder1,
- Piiha-Lotta Jerevall2,
- Rachel C. Jankowitz3,
- Tommy Fornander4,
- Olle Stål5,6,
- Adam M. Brufsky3,
- Dennis Sgroi2, and
- Mark G. Erlander1
- Authors' Affiliations: 1bioTheranostics, Inc., San Diego, California; 2Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; 3Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 4Department of Oncology, Karolinska University Hospital, Karolinska Institute, Stockholm; 5Department of Clinical and Experimental Medicine, Linköping University; and 6Department of Oncology, County Council of Östergötland, Linköping, Sweden
- Corresponding Author:
Mark G. Erlander, bioTheranostics, Inc., 9640 Towne Centre Dr, Ste 200, San Diego, CA 92121. Phone: 858-587-5860; E-mail: Mark.erlander{at}biotheranostics.com
August 2013
Volume 19, Issue 15
Volume 19, Issue 15
Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
Jump to section
Advertisement